Veterinary Oncology Market Analysis, Growth, Insights, Trends 2024-2033

The veterinary oncology market size has grown rapidly in recent years. It will grow from $0.36 billion in 2023 to $0.4 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing pet ownership, humanization of pets, knowledge transfer from human oncology, increasing awareness of pet health, pharmaceutical developments.

The veterinary oncology market size is expected to see rapidly grown in the next few years. It will grow to $0.62 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to personalized medicine for animals, rising prevalence of cancer in animals, growing geriatric pet population, expanded access to specialized care, regulatory support and approvals. Major trends in the forecast period include advanced diagnostic technologies, personalized treatment approaches, immunotherapy advancements, targeted therapies, telemedicine in oncology consultations.

Market Overview -
Veterinary oncology refers to the diagnosis and treatment of cancer by specially trained experts to integrate cancer treatment with underlying conditions with sustaining a quality of life in animals. It deals with cancer medicine and treatment services in animals.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Rising Pet Cancer Rates Propel Growth In The Veterinary Oncology Market
The growing prevalence of cancer in pets is expected to propel the veterinary oncology market going forward. Cancer is a disorder in which a few of the body's cells grow out of control and spread to other body sections. Cancer in pets refers to the physical manifestations of a tumor, such as swelling. Veterinary oncology is focused on cancer diagnosis and therapy in animals by reducing metastasis and disease spread. As a result, an increase in pet cancer will boost the need for veterinary oncology. For instance, according to the National Canine Cancer Foundation, a US-based foundation that strives to eliminate cancer in animals, in 2021, roughly 25% of purebred dogs pass away from cancer, with the probability of contracting the disease increasing to 45% for those over the age of ten. Furthermore, according to the National Library of Medicine, a US-based biomedical library, and the center of biomedical informatics, in 2021, approximately 4-6 million dogs are diagnosed with cancer in the 90 million total population of dogs in the US. Therefore, the growing prevalence of cancer in pets is driving the veterinary oncology market.

Competitive Landscape -
Major companies operating in the veterinary oncology market report are PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Siemens Healthineers AG Varian Medical Systems, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc. .

Cutting-Edge Multi-Cancer Early Detection Test Transforms The Market
Product innovations are a key trend gaining popularity in the veterinary oncology market. Major companies operating in the veterinary oncology market are focused on developing new solutions to strengthen their position. For instance, in June 2021, PetDx, a US-based molecular diagnostics company dedicated to unleashing the power of genomics, launched "OncoK9," a novel multi-cancer early detection test. It is uniquely designed with the power of genomics to help veterinarians detect cancer in dogs earlier by using routine blood drawing without the need for prior fasting or sample processing. It processes the sample using proprietary methods optimized for canine cell-free DNA analysis and issues a digital report indicating if there is a cancer signal. It has strong clinical performance with minimal false-positive rates and high cancer diagnosis rates.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Key Segments -

The veterinary oncology market covered in this report is segmented -

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies
2) By Animal Type: Equine, Canine, Feline, Other Animal Types
3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Key highlights covered in the report -

1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.